Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

12 Health Care Stocks Moving In Friday's After-Market Session

Author: Benzinga Insights | November 14, 2025 04:06pm

Gainers

  • Applied Therapeutics (NASDAQ:APLT) shares increased by 5.3% to $0.23 during Friday's after-market session. The company's market cap stands at $38.8 million. As per the press release, Q3 earnings came out yesterday.
  • Bio Green Med Solution (NASDAQ:BGMS) shares moved upwards by 4.58% to $1.37. The company's market cap stands at $3.9 million. The company's, Q3 earnings came out yesterday.
  • Abpro Hldgs (NASDAQ:ABP) shares rose 3.46% to $5.98. The market value of their outstanding shares is at $15.7 million.
  • Streamex (NASDAQ:STEX) shares rose 3.35% to $4.0. The company's market cap stands at $140.0 million.
  • Akanda (NASDAQ:AKAN) shares moved upwards by 2.56% to $1.2.
  • enVVeno Medical (NASDAQ:NVNO) shares moved upwards by 2.39% to $0.43. The market value of their outstanding shares is at $13.2 million.

Losers

  • GT Biopharma (NASDAQ:GTBP) shares declined by 7.7% to $0.85 during Friday's after-market session. The market value of their outstanding shares is at $7.7 million.
  • Annexon (NASDAQ:ANNX) shares decreased by 7.02% to $2.52. The company's market cap stands at $320.6 million. As per the news, the Q3 earnings report came out 4 days ago.
  • Cypherpunk Technologies (NASDAQ:CYPH) shares decreased by 6.55% to $2.57. The market value of their outstanding shares is at $99.7 million.
  • Check-Cap (NASDAQ:CHEK) stock decreased by 4.0% to $1.9. The company's market cap stands at $9.8 million.
  • DiaMedica Therapeutics (NASDAQ:DMAC) stock fell 3.55% to $5.72. The company's market cap stands at $282.2 million. The company's, Q3 earnings came out 2 days ago.
  • Eledon Pharmaceuticals (NASDAQ:ELDN) stock declined by 3.36% to $1.7. The market value of their outstanding shares is at $132.0 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ABP AKAN ANNX APLT BGMS CHEK CYPH DMAC ELDN GTBP NVNO STEX


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist